Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31640
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMiyakis, S-
dc.contributor.authorBrentnall, S-
dc.contributor.authorMasso, M-
dc.contributor.authorReynolds, G-
dc.contributor.authorByrne, M K-
dc.contributor.authorNewton, P-
dc.contributor.authorCrawford, S-
dc.contributor.authorFish, J-
dc.contributor.authorNicholas, B-
dc.contributor.authorHill, T-
dc.contributor.authorvan Oijen, A M-
dc.date2022-
dc.date.accessioned2023-01-12T01:38:46Z-
dc.date.available2023-01-12T01:38:46Z-
dc.date.issued2022-11-
dc.identifier.citationThe Journal of Hospital Infection 2022; 129en_US
dc.identifier.issn1532-2939-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31640-
dc.description.abstractStaphylococcus aureus is associated with significant mortality and increased burden on the healthcare system. Relatively few reliable estimates are available regarding the impact of meticillin-resistant S. aureus (MRSA) infection compared with meticillin-susceptible S. aureus (MSSA) infection.en_US
dc.language.isoeng-
dc.subjectAntimicrobial resistanceen_US
dc.subjectBurdenen_US
dc.subjectCosten_US
dc.subjectLength of stayen_US
dc.subjectMortalityen_US
dc.subjectStaphylococcus aureusen_US
dc.titleKey predictors and burden of meticillin-resistant Staphylococcus aureus infection in comparison with meticillin-susceptible S. aureus infection in an Australian hospital setting.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe Journal of Hospital Infectionen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Wollongong Hospital, Wollongong, New South Wales, Australia.en_US
dc.identifier.affiliationGraduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australiaen_US
dc.identifier.affiliationIllawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.en_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationMolecular Horizons Institute and School of Chemistry and Biomolecular Science, University of Wollongong, Wollongong, New South Wales, Australiaen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Wollongong Hospital, Wollongong, New South Wales, Australiaen_US
dc.identifier.affiliationSchool of Psychology, University of Wollongong, Wollongong, New South Wales, Australia.en_US
dc.identifier.affiliationAustralian Health Services Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.en_US
dc.identifier.affiliationCollege of Health and Human Sciences, Charles Darwin University, Darwin, Northern Territory, Australia.en_US
dc.identifier.affiliationMicrobiology, NSW Health Pathology, Wollongong Hospital, Wollongong, New South Wales, Australia.en_US
dc.identifier.affiliationResearch Office, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia.en_US
dc.identifier.doi10.1016/j.jhin.2022.07.004en_US
dc.type.contentTexten_US
dc.identifier.pubmedid35839999-
dc.description.volume129-
dc.description.startpage41-
dc.description.endpage48-
dc.subject.meshtermssecondaryMethicillin/pharmacology-
dc.subject.meshtermssecondaryAustralia/epidemiology-
local.name.researcherHill, Bridget
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptPlastic and Reconstructive Surgery-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Nov 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.